GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹4.71 Cr | ₹3.73 Cr | ₹4.03 Cr | ₹4.00 Cr | ₹3.88 Cr |
What is the latest Contingent Liabilities ratio of GUJARAT THEMIS BIOSYN ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹4.71 Cr |
| Mar2024 | ₹3.73 Cr |
| Mar2023 | ₹4.03 Cr |
| Mar2022 | ₹4.00 Cr |
| Mar2021 | ₹3.88 Cr |
How is Contingent Liabilities of GUJARAT THEMIS BIOSYN Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.71 Cr | 26.36 | |
| Mar2024 | ₹3.73 Cr | -7.56 | |
| Mar2023 | ₹4.03 Cr | 0.98 | |
| Mar2022 | ₹4.00 Cr | 3.10 | |
| Mar2021 | ₹3.88 Cr | - | |
Compare Contingent Liabilities of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹4,198.7 Cr | -2.9% | -6.4% | 10.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | -2.9% |
-6.4% |
10.5% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses